CTTNBP2NL

Across TCGA pan-cancer cohorts, CTTNBP2NL RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of CTTNBP2NL’s most consistent transcriptional readouts.

The strongest signal is observed in kidney chromophobe (KICH), where CTTNBP2NL RNA is repressed in tumor relative to normal tissue. In most cancer types CTTNBP2NL is over-expressed in tumor, although a few such as KICH and COAD show the opposite, repressed pattern.

KICH, KIRP, and LIHC are the cancer types where CTTNBP2NL tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CTTNBP2NL RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KICH	Female	All	−2.097	<.001	8	view →
KIRP	All	All	+0.646	.001	8	view →
LIHC	Female	All	+0.785	<.001	6	view →
CHOL	Female	All	+3.010	<.001	5	view →
BLCA	All	III,IV	+0.474	.028	4	view →
KIRC	All	All	+0.438	<.001	4	view →
COAD	All	All	−0.337	.006	4	view →
LUSC	All	II,III,IV	−0.346	.036	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

CTTNBP2NL–KICH

Open the KICH breakdown →